Literature DB >> 20632386

Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis.

Dei Kui Zhang1, Fu Qian He, Tian Ke Li, Xue Hua Pang, De Jun Cui, Qin Xie, Xiao Li Huang, Hua Tian Gan.   

Abstract

Although enteric glial cells (EGCs) have been demonstrated to play a key role in maintaining intestinal epithelial barrier integrity, it is not known how EGCs regulate this integrity. We therefore hypothesized that glial-derived neurotrophic factor (GDNF) produced by EGCs might be involved in this regulation. Here we investigated the role of GDNF in regulating epithelial barrier function in vivo. Recombinant adenoviral vectors encoding GDNF (Ad-GDNF) were administered intracolonically in experimental colitis induced by dextran sulphate sodium (DSS). The disease activity index (DAI) and histological score were measured. Epithelial permeability was assayed using Evans blue dye. The anti-apoptotic potency of GDNF in vivo was evaluated. The expression of tumour necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and myeloperoxidase (MPO) activity were measured by ELISA assay and/or RT-PCR. The expression of ZO-1, Akt, caspase-3, and NF-kappaB p65 was analysed by western blot assay. Our results showed that GDNF resulted in a significant reduction in enhanced permeability, inhibited MPO activity, IL-1beta and TNF-alpha expression, and increased ZO-1 and Akt expression. Moreover, GDNF strongly prevented apoptosis in vivo and significantly ameliorated experimental colitis. Our findings indicate that GDNF participates directly in restoring epithelial barrier function in vivo via reduction of increased epithelial permeability and inhibition of mucosal inflammatory response, and is efficacious in DSS-induced colitis. These findings support the notion that EGCs are able to regulate intestinal epithelial barrier integrity indirectly via their release of GDNF in vivo. GDNF is namely an important mediator of the cross-talk between EGCs and mucosal epithelial cells. GDNF may be a useful therapeutic approach to the treatment of inflammatory bowel disease. Copyright 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20632386     DOI: 10.1002/path.2749

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

Review 1.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

2.  Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis.

Authors:  Gilad Halpert; Tom Eitan; Elena Voronov; Ron N Apte; Lea Rath-Wolfson; Michael Albeck; Yona Kalechman; Benjamin Sredni
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

3.  Molecular Mechanisms Underlying How Sialyllactose Intervention Promotes Intestinal Maturity by Upregulating GDNF Through a CREB-Dependent Pathway in Neonatal Piglets.

Authors:  Changwei Yang; Panwang Zhang; Wang Fang; Yue Chen; Nai Zhang; Zhiliang Qiao; Frederic A Troy; Bing Wang
Journal:  Mol Neurobiol       Date:  2019-06-03       Impact factor: 5.590

Review 4.  The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease.

Authors:  Michel Neunlist; Laurianne Van Landeghem; Maxime M Mahé; Pascal Derkinderen; Stanislas Bruley des Varannes; Malvyne Rolli-Derkinderen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 5.  Enteric glial cells and their role in the intestinal epithelial barrier.

Authors:  Yan-Bo Yu; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 6.  Enteric glia: the most alimentary of all glia.

Authors:  Vladimir Grubišić; Brian D Gulbransen
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

7.  Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease.

Authors:  Michael Meir; Natalie Burkard; Hanna Ungewiß; Markus Diefenbacher; Sven Flemming; Felix Kannapin; Christoph-Thomas Germer; Matthias Schweinlin; Marco Metzger; Jens Waschke; Nicolas Schlegel
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

8.  Diet-induced obesity has neuroprotective effects in murine gastric enteric nervous system: involvement of leptin and glial cell line-derived neurotrophic factor.

Authors:  Charlotte Baudry; François Reichardt; Justine Marchix; André Bado; Michael Schemann; Stanislas Bruley des Varannes; Michel Neunlist; Raphaël Moriez
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

9.  The novel insight into anti-inflammatory and anxiolytic effects of psychobiotics in diabetic rats: possible link between gut microbiota and brain regions.

Authors:  Elaheh-Sadat Hosseinifard; Mohammad Morshedi; Khadijeh Bavafa-Valenlia; Maryam Saghafi-Asl
Journal:  Eur J Nutr       Date:  2019-03-02       Impact factor: 5.614

10.  GDNF is involved in the barrier-inducing effect of enteric glial cells on intestinal epithelial cells under acute ischemia reperfusion stimulation.

Authors:  Weidong Xiao; Wensheng Wang; Wei Chen; Lihua Sun; Xiangsheng Li; Chaojun Zhang; Hua Yang
Journal:  Mol Neurobiol       Date:  2014-05-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.